Sequoia Pharmaceuticals is a private, venture-capital funded company. Company is engaged in the discovery and development of novel antiviral therapeutics with a focus on combating drug-resistant HIV and HCV. Sequoia is also developing pharmacokinetic enhancers to improve the exposure of co-administered therapeutics.